About us
Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories. AMCo is the result of the merger of Amdipharm and the Mercury Pharma Group to create a single, consolidated, international specialty pharmaceuticals company by the company's private equity owners, Cinven.Latest News
01/05/2013: New website launched for Amdipharm Mercury (AMCo)
We are proud to announce the launch of our new website: www.amcolimited.com with effect from 1 May 2013.